Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

Clinical trial NCT06909383 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06909383
Sponsor: Guangzhou Institute of Respiratory Disease
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)Cancer - Associated Anorexia - Cachexia Syndrome

Start date: 2025-06-01
Primary completion: 2026-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.